Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact

RMF’s Bernie Siegel talks with Michael May of CCRM about the future of stem cell development

by Admin | Jul 27, 2020 | News & Opinions, Video, Video Chats | 0 comments

Michael May, CEO of Centre for Commercialization of Regenerative Medicine (Canada)

More Posts from News Feed

  • Regenerative Medicine Foundation Announces 2019 "Stem Cell and Regenerative Medicine Action Award" Honorees
    Regenerative Medicine Foundation Announces 2019…
  • 2023-WSCS-featured-image-2
    Regenerative Medicine Essentials Course and World…
  • Anemocyte to Sponsor Inspirational ‘Phacilitate:TALKS’ stage featuring Spark Therapeutics, Dendreon, Genenta and Space Tango
    Anemocyte to Sponsor Inspirational…

Recent Posts

  • Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
  • Embryonic macrophages found to control blood stem cell numbers in bone marrow
  • Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
  • Infant becomes world’s first patient to undergo personalized gene-editing treatment
  • Stem cell model replicates human amniotic sac development past two weeks
Tweets about @WSCSummit

Notifications